Search Results 251-260 of 14933 for infliximab

  1. Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch - Mayo Clinic

    About this study. The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer ...

  2. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    TNF-alpha inhibitors including but not limited to infliximab (Remicade) or adalimumab (Humira) within 12 weeks of Day 0; Any biological agent within 12 weeks ...

  3. Obiltoxaximab (intravenous route) - Side effects & uses - Mayo Clinic

    Obiltoxaximab injection is used together with antibiotics to treat inhalational anthrax. It is also used to prevent inhalational anthrax after a person is ...

  4. Mayo Clinic

    Home · infographic-proton-beam-therapy-app-thumbnail-640x440 ...

  5. Assessing Benefits And Harms Of Cannabis/Cannabinoid Use Among Cancer Patients Treated In Community Oncology Clinics

    * Participants with chronic or ongoing steroid or immunomodulatory agents (i.e., prednisone, dexamethasone, etanercept, infliximab, etc.). The use of ...

  6. Mayo Clinic

    Mayo Clinic Proton Beam Therapy Program. Narrator: Mayo Clinic's Cancer Center offers a full range of services and treatment options to meet your individual ...

  7. Nipocalimab-aahu (intravenous route) - Mayo Clinic

    Nipocalimab-aahu injection is used to treat a nerve and muscle disease called generalized myasthenia gravis (gMG) in patients who are anti-acetylcholine ...

  8. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

  9. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

  10. Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps - Mayo Clinic

    Current or planned use of immunomodulators including: infliximab, 6‐MP (mercaptopurine), methotrexate, cyclosporine, or other immunomodulatory drugs; History ...